91 Matching Annotations
  1. Feb 2025
  2. Aug 2022
  3. Apr 2022
  4. Mar 2022
  5. Feb 2022
  6. Jan 2022
  7. Dec 2021
  8. Nov 2021
  9. Oct 2021
  10. Sep 2021
    1. Twohig, K. A., Nyberg, T., Zaidi, A., Thelwall, S., Sinnathamby, M. A., Aliabadi, S., Seaman, S. R., Harris, R. J., Hope, R., Lopez-Bernal, J., Gallagher, E., Charlett, A., Angelis, D. D., Presanis, A. M., Dabrera, G., Koshy, C., Ash, A., Wise, E., Moore, N., … Gunson, R. (2021). Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: A cohort study. The Lancet Infectious Diseases, 0(0). https://doi.org/10.1016/S1473-3099(21)00475-8

  11. Jul 2021
  12. Jun 2021
  13. May 2021
  14. Mar 2021
  15. Feb 2021
  16. Jan 2021
  17. Dec 2020
    1. Emily. J. Miller. - FDA {@FDASpox} (2020) Convalescent plasma has shown to be beneficial for 35% of patients. This risk reduction figure - shown in chart below - is from @MayoClinic data from expanded access program that was analyzed by FDAA for the emergency use authorization announced today. Twitter. Retrieved from: https://twitter.com/FDASpox/status/1297706985039835136

  18. Oct 2020
  19. Sep 2020
  20. Aug 2020
    1. Malani, A., Soman, S., Asher, S., Novosad, P., Imbert, C., Tandel, V., Agarwal, A., Alomar, A., Sarker, A., Shah, D., Shen, D., Gruber, J., Sachdeva, S., Kaiser, D., & Bettencourt, L. M. A. (2020). Adaptive Control of COVID-19 Outbreaks in India: Local, Gradual, and Trigger-based Exit Paths from Lockdown (Working Paper No. 27532; Working Paper Series). National Bureau of Economic Research. https://doi.org/10.3386/w27532

  21. Jul 2020
  22. Jun 2020
  23. May 2020
  24. Apr 2020